Lung carcinomas exhibiting high and negative PD-L1 expression demonstrate distinct methylation patterns, and their pathobiology indicates different paths through various mechanisms by which PD-L1 high-expressing and PD-L1 negative-expressing lung cancers develop. This evidence concerns the gene CD274 and lung cancer.